<
Back to Previous Page
Article Summary: Sibutramines mechanism of action inhibiting the reuptake of serotonin and norepinephrine is similar to that of some antidepressants
Pediatric Exclusivity Labeling Changes For Meridia
The data are inadequate to recommend the use of sibutramine for the treatment of obesity in pediatric patients efficacy in obese adolescents has not been adequately studied Sibutramine's mechanism of action inhibiting the reuptake of serotonin and norepinephrine is similar to that of some antidepressants.
It is unknown if sibutramine increases the risk of suicidal behavior or thinking in pediatric patients - In a study of adolescents with obesity in which 368 patients were treated with sibutramine and 130 patients with placebo, one patient in each group attempted suicide. Suicidal ideation was reported by 2 sibutramine-treated patients and none of the placebo patients. If you or anyone you know has taken Meridia and has experienced any negative symptoms or side-effects, please contact our expert lawyers and obtain a case evaluation at no cost to you..
|
